Advances in mechanisms, combined therapeutic strategies and dual-target inhibitors for synergistic antitumor effects of HDAC and PD-1/PD-L1 pathway
Fields of Study & Subjects
Histone Deacetylase Inhibitors Research
Cancer Immunotherapy and Biomarkers
Protein Degradation and Inhibitors
Publication details
- Journal / source
- Bioorganic Chemistry
- Volume
- 172
- Pages
- 109541–109541
- Publication date
- 29 January 2026
- Language
- EN